| MEDI | Sunday, March 25, 2007 | ||
9:00 AM-1:00 PM McCormick Place Lakeside -- Room E353 A/B, Level 3, Oral | |||
Fragment-Based Drug Discovery | |||
| Sponsored by: | MEDI | ||
| Cosponsored by: | Teledyne Isco | ||
| Organizer, Presiding: | Jeffrey S. Albert | ||
| 9:00 AM | 1 | Fragment based drug design Michael Shapiro | |
| 9:40 AM | 2 | Fragment screening and its application to drug design: The discovery of low molecular weight, non-peptidic, nanomolar inhibitors of beta-secretase Philip D Edwards | |
| 10:20 AM | 3 | Fragment to lead evolution using chemical microarray screening Hans-Dieter Junker, Thomas Neumann, Inge Ott, Klaus Burkert, Oliver Keil, Kristina Schmidt, Renate Sekul | |
| 11:00 AM | 4 | Structure activity relationships by mass spectrometry: Discovery of novel MMP3 inhibitors Denise A. Ockey, Tom R. Gadek | |
| 11:40 AM | 5 | Fragment-based drug discovery: From crystal to clinic Steven Howard | |
| 12:20 PM | 6 | Strategies and experiences in fragment-based drug discovery Roderick E Hubbard | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
Symposium Grid -- Biotechnology -- Session Listing
The 233rd ACS National Meeting, Chicago, IL, March 25-29, 2007